Through this study, we preliminarily confirmed that Ansofaxine hydrochloride has the effect of inhibiting hepatocellular carcinoma cell growth and may be closely related to inhibiting EGFR/MAPK. Here, EGFR is linked to hepatocellular carcinoma.